Unknown OBSERVATIONAL NCT05006456

Real-world Experience of Catheter Ablation Using Novel Ablation Technologies for the Treatment of Atrial Fibrillation (NOVEL AF)

Real-world Experience of Catheter Ablation Using Novel Ablation Technologies Associated With the Carto System for the Treatment of Symptomatic Paroxysmal and Persistent Atrial Fibrillation (NOVEL AF)

Sponsor: Beijing Anzhen Hospital

Conditions Paroxysmal Atrial Fibrillation Persistent Atrial Fibrillation

Interventions Catheter ablation

Updated 5 times since 2021 Last updated: Dec 6, 2021 Started: Jan 1, 2022 Primary completion: Sep 30, 2025 Completion: Jan 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05006456, this observational or N/A phase trial focuses on Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation and remains ongoing. Sponsored by Beijing Anzhen Hospital, it has been updated 5 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Feb 2026 — Present [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Jan 2022 — Jul 2024 [monthly]

Not Yet Recruiting
Sep 2021 — Jan 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Anzhen Hospital
Heart Health Research Center
Johnson & Johnson

Data source: Beijing Anzhen Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.